Cargando…
Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?
Autor principal: | Burnier, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343241/ https://www.ncbi.nlm.nih.gov/pubmed/34386753 http://dx.doi.org/10.1016/j.eclinm.2021.100983 |
Ejemplares similares
-
Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection
por: Berbari, Adel E.
Publicado: (2020) -
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney
transplant recipients: what is the evidence?
por: Ujjawal, Aditi, et al.
Publicado: (2022) -
The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
por: Cherney, David, et al.
Publicado: (2017) -
A Call for a New Paradigm for Diabetes Care in the Era of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i)
por: Kim, Sun H., et al.
Publicado: (2020) -
Combined effect of sodium–glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease
por: Araki, Shin‐ichi
Publicado: (2019)